Home / EPRX.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does EPRX.TO make money? Does EPRX.TO have pricing power? What's the Earnings Whisper? Will EPRX.TO profit more as the business scales? What is EPRX.TO's management track record? Is EPRX.TO's current price justified?

Eupraxia Pharmaceuticals Inc.

CAD 11.21 +$0.75 (+7.17%)

TSX · 14 Sep 2026 20:00 UTC

Previous Close

CAD 11.69

Day Range

CAD 11.13CAD 11.71

Year Range

CAD 7.15CAD 12.86

Market Cap

402.86M

AVG Volume

64.48K

Trailing/Forward PE

-7.91/-

PEG ratio

-0.55

Dividend Yield

Next Earnings Date

2026-11-03

Primary Exchange

Toronto Stock Exchange

Net Income (USD)

EPRX.TO Net Income (USD) by year
Period	Net Income (USD)
2025	-38.83M
2024	-23.84M
2023	-29.61M
2022	-23.26M
2021	-22.99M
2020	-4M

Operating Income (USD)

EPRX.TO Operating Income (USD) by year
Period	Operating Income (USD)
2025	-38.68M
2024	-26.96M
2023	-33.52M
2022	-28.37M
2021	-18.48M
2020	-2.47M

EBITDA (USD)

EPRX.TO EBITDA (USD) by year
Period	EBITDA (USD)
2025	-33.74M
2024	-21.82M
2023	-26.01M
2022	-17.26M
2021	-21.96M
2020	-1.48M

Cash Flows (USD)

EPRX.TO Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-28.01M
2024	-27.36M
2023	-25.84M
2022	-19.08M
2021	-15.07M
2020	-403.93K

EPS (USD)

EPRX.TO EPS (USD) by year
Period	EPS (USD)
2025	-1
2024	-0.68
2023	-1.44
2022	-1.16
2021	-1.74
2020	-0.25

Expenses (USD)

EPRX.TO Expenses (USD) by year
Period	Expenses (USD)
2025	34.73M
2024	21.32M
2023	32.34M
2022	28.48M
2021	19.02M
2020	2.84M

Cash & Debt (USD)

EPRX.TO Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	80.42M
2024	33.1M
2023	14.56M
2022	24.74M
2021	29.9M
2020	150.13K

Debt ratios

EPRX.TO Debt ratios by year
Period	Debt ratios
2025	0.81
2024	0.38
2023	0.1

Return on Capital

EPRX.TO Return on Capital by year
Period	Return on Capital
2025	-48.36%
2024	-74.88%
2023	-4407.58%
2022	-204.68%
2021	-117.58%
2020	18.45%

Shares Outstanding

EPRX.TO Shares Outstanding by year
Period	Shares Outstanding
2025	51.94M
2024	35.64M
2023	27.31M
2022	21.59M
2021	12.41M
2020	12.87M

Book Value Per Share (USD)

EPRX.TO Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	1.55
2024	0.89
2023	0.02
2022	0.53
2021	1.58
2020	-1.68

Total Assets (USD)

EPRX.TO Total Assets (USD) by year
Period	Total Assets (USD)
2025	85.99M
2024	34.94M
2023	15.26M
2022	25.88M
2021	31.22M
2020	1.45M

Free Cash Flow Yield

EPRX.TO Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-6.72%
Sep 26	-6.73%
Aug 26	-8.49%
Aug 26	-8.39%
Aug 26	-8.44%
Aug 26	-8.35%
Jul 26	-8.84%
Jul 26	-9.72%
Jul 26	-8.57%
Jul 26	-8.48%
Jul 26	-8.45%
Jun 26	-8.16%
Jun 26	-8.42%
Jun 26	-8.93%
Jun 26	-9.02%
May 26	-7.49%
May 26	-7.68%
May 26	-7.77%
May 26	-7.15%
May 26	-6.82%
Apr 26	-7.46%
Apr 26	-7.58%
Apr 26	-7.84%
Apr 26	-7.54%
Mar 26	-10.67%
Mar 26	-10.02%
Mar 26	-9.67%
Mar 26	-8.89%
Feb 26	-8.76%
Feb 26	-8.37%
Feb 26	-8.48%
Feb 26	-8.53%
Jan 26	-8.66%
Jan 26	-7.93%
Jan 26	-8.13%
Jan 26	-8.84%
Jan 26	-9.39%
Dec 25	-9.76%
Dec 25	-10.83%
Dec 25	-11.41%
Dec 25	-11.57%
Nov 25	-11.44%
Nov 25	-11.35%
Nov 25	-10.78%
Nov 25	-13.08%
Oct 25	-13.75%
Oct 25	-14.37%
Oct 25	-13.56%
Oct 25	-13.09%
Oct 25	-13.47%
Sep 25	-13.42%
Sep 25	-12.87%
Sep 25	-14.48%
Sep 25	-14.42%
Aug 25	-14.24%
Aug 25	-14.5%
Aug 25	-14.41%
Aug 25	-14.67%
Aug 25	-14.48%
Jul 25	-13.95%
Jul 25	-14.65%
Jul 25	-13.79%
Jul 25	-13.67%
Jun 25	-14.28%
Jun 25	-17.48%
Jun 25	-19.48%
Jun 25	-19.79%
May 25	-19.74%
May 25	-20.03%
May 25	-20.04%
May 25	-19.8%
May 25	-19.24%
Apr 25	-19.9%
Apr 25	-23.28%
Apr 25	-25.7%
Apr 25	-26.31%
Mar 25	-23.08%
Mar 25	-20.98%
Mar 25	-18.47%
Mar 25	-18.34%
Feb 25	-19.47%
Feb 25	-20.66%
Feb 25	-24.02%
Feb 25	-23.83%
Jan 25	-25.05%
Jan 25	-25.3%
Jan 25	-24%
Jan 25	-25.61%
Jan 25	-25.25%
Dec 24	-25.01%
Dec 24	-25.86%
Dec 24	-22.86%
Dec 24	-25.01%
Nov 24	-22.87%
Nov 24	-22.18%
Nov 24	-25.06%
Nov 24	-24.62%
Nov 24	-25.27%
Oct 24	-31.55%
Oct 24	-30.72%

Price to Book

EPRX.TO Price to Book by year
Period	Price to Book
Sep 26	3.51
Sep 26	3.5
Aug 26	2.78
Aug 26	2.81
Aug 26	2.79
Aug 26	2.82
Jul 26	2.67
Jul 26	2.43
Jul 26	2.75
Jul 26	2.78
Jul 26	2.79
Jun 26	4.28
Jun 26	4.14
Jun 26	3.91
Jun 26	3.87
May 26	4.66
May 26	4.54
May 26	4.49
May 26	4.88
May 26	5.12
Apr 26	4.68
Apr 26	4.6
Apr 26	4.45
Apr 26	4.62
Mar 26	2.54
Mar 26	2.71
Mar 26	2.81
Mar 26	3.05
Feb 26	3.1
Feb 26	3.24
Feb 26	3.2
Feb 26	3.18
Jan 26	3.14
Jan 26	3.42
Jan 26	3.34
Jan 26	3.07
Jan 26	2.89
Dec 25	2.78
Dec 25	2.51
Dec 25	2.38
Dec 25	2.35
Nov 25	2.37
Nov 25	2.39
Nov 25	2.52
Nov 25	2.07
Oct 25	9.78
Oct 25	9.36
Oct 25	9.92
Oct 25	10.27
Oct 25	9.98
Sep 25	7.57
Sep 25	7.89
Sep 25	7.01
Sep 25	7.04
Aug 25	7.13
Aug 25	7
Aug 25	7.04
Aug 25	6.92
Aug 25	7.01
Jul 25	7.28
Jul 25	6.93
Jul 25	7.36
Jul 25	7.43
Jun 25	6.02
Jun 25	4.92
Jun 25	4.41
Jun 25	4.34
May 25	4.35
May 25	4.29
May 25	4.29
May 25	4.34
May 25	4.47
Apr 25	4.32
Apr 25	3.69
Apr 25	3.34
Apr 25	3.27
Mar 25	14.85
Mar 25	16.34
Mar 25	18.55
Mar 25	18.69
Feb 25	17.6
Feb 25	16.59
Feb 25	14.27
Feb 25	14.38
Jan 25	13.68
Jan 25	13.55
Jan 25	14.28
Jan 25	13.38
Jan 25	13.57
Dec 24	8.32
Dec 24	8.05
Dec 24	9.1
Dec 24	8.32
Nov 24	9.1
Nov 24	9.39
Nov 24	8.31
Nov 24	8.45
Nov 24	8.24
Oct 24	6.6
Oct 24	6.78

No video analysis for this stock yet. Request one from our team.

AI Analysis

Eupraxia Pharmaceuticals Inc.

Video analysis: EPRX.TO

Similar companies